SCHEDULE: Vanguard Amends DaVita Stake to 5.91%

The Vanguard Group has filed an amended Schedule 13G, disclosing a 5.91% beneficial ownership stake in DaVita Inc. as of September 30, 2025.

Summary

• The Vanguard Group reported beneficial ownership of 4,227,904 shares of DaVita Inc. common stock.
• This represents 5.91% of DaVita Inc.'s outstanding common stock.
• The filing is an Amendment No. 14 to a previously filed Schedule 13G.
• The Vanguard Group holds sole voting power over 0 shares and shared voting power over 214,553 shares.
• The Vanguard Group holds sole dispositive power over 3,919,715 shares and shared dispositive power over 308,189 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of DaVita Inc.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine disclosure of institutional ownership, neither inherently positive nor negative for the issuer's operational or financial performance.

Future Outlook

NA

Management Comments

• The Vanguard Group certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a routine disclosure of an institutional investor's stake and does not provide specific insights into broader industry trends or competitive dynamics within the healthcare services sector, beyond indicating continued institutional interest in DaVita Inc.

Stakeholder Impact

• Indicates continued institutional investor interest in DaVita Inc. shares.
• Provides transparency to shareholders and the market regarding a significant institutional holder's stake.

Key Dates

Keywords

DaVita Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Healthcare Services